FINWIRES · TerminalLIVE
FINWIRES

Axon Enterprise to Raise 2026 Sales Guidance Supported by AI, New Products, RBC Says

By

-- Axon Enterprise (AXON) could beat Q1 estimates and raise the lower end of its fiscal 2026 revenue guidance as new products, wider use of its platform, AI add-ons, and faster drone deployments support growth, RBC Capital Markets said in a note Tuesday.

Axon's connected system should become stronger through fiscal 2026 as ABW Mini launches and drone-as-first-responder deployments send more real-time data into its Fusus and intelligence platforms. Its AI Era Plan conversions are expected to grow faster, helped by bundled products, customer upgrades, international expansion, and more federal and enterprise demand, RBC said.

Bookings may be seasonally softer in Q1, but growth should pick up later in fiscal 2026 as deal sizes rise and new products gain more traction, while international growth will slow down in 2026 because of long European sales cycles, but stronger gains are expected in 2027 and 2028 as cloud deployments expand and AI tools drive more platform use, according to the note.

The investment firm said Axon's mix of hardware, software, and data gives it a stronger position against lower-cost software rivals and supports wider customer adoption.

RBC maintained its outperform rating and $735 price target on the stock.

Price: $373.46, Change: $-20.29, Percent Change: -5.15%

Related Articles

Australia

American Electric Power CEO Says Speed to Market Key Issue in Load Connection

American Electric Power (AEP) CEO Bill Fehrman said Tuesday that speed to market is the main issue in efficiently connecting energy load to generation.In a Q1 earnings call, Fehrman said that, in particular, the performance and stakeholder approval process of PJM, the US mid-Atlantic grid operator, represents a major challenge."The current state of PJM's performance and stakeholder approval process does not give me great confidence that these issues will be resolved any time soon," Fehrman said on the call."In fact, if something is not done now, I expect we could still be having these same conversations in 10 years," he added.Expanding and strengthening the grid will ensure new generation resources can connect quickly, reliably, and affordably to serve the growing load, the CEO said.Price: $137.27, Change: $+2.61, Percent Change: +1.94%

$AEP
Australia

MGE Energy Q1 Earnings, Revenue Rise

MGE Energy (MGEE) reported Q1 earnings Tuesday of $1.32 per diluted share, up from $1.14 a year earlier.One analyst polled by FactSet expected $1.13.Revenue for the three months ended March 31 was $242.7 million, up from $219 million a year earlier.Price: $80.48, Change: $+0.36, Percent Change: +0.46%

$MGEE
Research

Research Alert: CFRA Lowers Rating On Shares Of Pfizer Inc. To Hold From Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target to $28 from $31, 9.4x our 2027 EPS estimate, below PFE's historical forward P/E average. We keep our 2026 EPS view at $2.99 and our 2027 EPS at $2.97. PFE delivered solid top- and bottom-line Q1 results today that exceeded expectations while demonstrating continued progress in its post-Covid transition strategy. While we continue to think that shares are trading at a discount, as the company's main focus in the next year is on AI integration, and a new transformative M&A is not a key priority, we see limited catalysts to drive meaningful upside potential. We think PFE is aiming to maximize value from launched and acquired products with particular focus on key areas: oncology, obesity/metabolic disease, and vaccines. PFE remains committed to maintaining its dividend, continuing productivity initiatives ($7.2B cost savings target), and pursuing targeted business development (with $7B capacity) but we do not expect PFE executing share buybacks to support the share price in the near term.

$PFE